drugset / Trial / NCT01068028

Safety and Pharmacokinetic Study With Multiple Ascending Doses of ORM-12741

NCT01068028 ↗

Phase 1 Completed 49 enrolled Orion Corporation, Orion Pharma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and tolerability of multiple ascending doses of ORM-12741.

Timeline

Start
2010-02
Primary completion
2010-06
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject ORM-12741 Small molecule — —

Indications

No indication recorded.